Table 6 Characteristics of Patients With Early and Late Stent Thrombosis*
| Patient # |
Stent Type |
Age (yrs), Gender |
Smoking |
Unstable Angina |
Days to ST |
Angiographically Confirmed |
Treated Vessel |
Stent Diameter (mm) |
Stent Length (mm) |
Medication Status |
Clinical Sequelae |
Death (Immediate or In Hospital) |
ST Caused Death |
|
| 1 |
Taxus SR |
50, male |
Yes |
Yes |
0 |
Yes |
RCA |
3.5 |
15 |
ASA: none |
NQWMI, TLR |
No |
No |
| Clopidogrel: none |
| 2 |
Taxus SR |
50, male |
Yes |
Yes |
0 |
Yes |
LAD |
3.0 |
32 |
ASA: 325 mg |
NQWMI, TLR |
No |
No |
| Clopidogrel: none |
| 3 |
Taxus SR |
52, male |
Yes |
No |
1 |
Yes |
RCA |
3.5 |
36 |
ASA: 325 mg |
QWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 4 |
Taxus SR |
68, male |
No |
No |
2 |
Yes |
CX |
2.25 |
20 |
ASA: 325 mg |
TLR |
No |
No |
| Clopidogrel: 75 mg |
| 5 |
Taxus SR |
48, male |
Yes |
No |
5 |
Yes |
CX |
3.5 |
40 |
ASA: 325 mg |
NQWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 6 |
Taxus MR |
68, male |
Yes |
Yes |
6 |
Yes |
CX |
2.5 |
24 |
ASA: 80 mg |
NQWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 7 |
Taxus SR |
41, male |
No |
Yes |
7 |
No |
CX |
3.0 |
32 |
ASA: 325 mg |
Cardiac death |
Yes |
Yes |
| Clopidogrel: 75 mg |
| 8 |
Taxus SR |
77, male |
No |
Yes |
7 |
No |
LAD |
2.5 |
24 |
ASA: 325 mg |
Cardiac death |
Yes |
Yes |
| Clopidogrel: 75 mg |
| 9 |
Taxus SR |
51, male |
No |
No |
38 |
Yes |
LAD |
3.0 |
32 |
ASA: none |
QWMI, TLR, cardiac death |
No |
No |
| Clopidogrel: none, stopped 4 days prior |
| 10 |
Taxus SR |
62, male |
No |
No |
48 |
Yes |
LAD |
3.5 |
32 |
ASA: none |
QWMI |
No |
No |
| Clopidogrel: none, stopped 7 days prior |
| 11 |
BMS |
65, male |
No |
No |
0 |
Yes |
RCA |
3.5 |
16 |
ASA: 325 mg |
NQWMI, cardiac death |
Yes |
Yes |
| Clopidogrel: loading dose day of procedure/event |
| 12 |
BMS |
70, male |
No |
Yes |
1 |
Yes |
LAD |
3.0 |
48 |
ASA: 325 mg |
QWMI, TLR |
Yes |
Yes |
| Clopidogrel: 75 mg |
| 13 |
BMS |
75, male |
No |
No |
22 |
Yes |
CX |
2.5 |
16 |
ASA: 325 mg |
QWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 14 |
BMS |
83, male |
No |
No |
22 |
No |
CX |
3.0 |
16 |
ASA: 325 mg |
Cardiac death |
No |
Yes |
| Clopidogrel: 75 mg |
| 15 |
BMS |
40, male |
No |
Yes |
74 |
Yes |
CX |
2.5 |
24 |
ASA: 325 mg |
NQWMI |
No |
No |
| Clopidogrel: 75 mg |
| 16 |
BMS |
42, male |
Unknown |
No |
0 |
Yes |
LAD |
2.5 |
16 |
ASA: 325 mg |
NQWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 17 |
BMS |
45, female |
Yes |
Yes |
8 |
Yes |
CX |
2.25 |
16 |
ASA: 325 mg only on morning ST |
NQWMI, TLR |
No |
No |
| Clopidogrel: none |
| 18 |
BMS |
66, male |
No |
No |
8 |
Yes |
LAD |
2.5 |
16 |
ASA: 325 mg |
QWMI, TLR |
No |
No |
| Clopidogrel: 75 mg |
| 19 |
BMS |
66, male |
No |
No |
75 |
No |
LAD |
3.0 |
20 |
ASA: 325 mg |
Cardiac death |
No |
No |
| Clopidogrel: 75 mg |
| 20 |
BMS |
64, male |
Yes |
No |
0 |
Yes |
RCA |
3.0 |
24 |
ASA: 325 mg |
TLR, non-TVR |
No |
No |
| Clopidogrel: 75 mg post-procedure |
| 21 |
BMS |
45, male |
Yes |
No |
20 |
No |
LAD |
3.0 |
32 |
ASA: None |
NQWMI |
No |
No |
| Clopidogrel: none |
|
* Early stent thrombosis is defined as any stent thrombosis occurring 30 days; Late stent thrombosis is defined as any stent thrombosis occurring 31 to 180 days. |
|
ASA = aspirin; CX = circumflex; NQWMI = non–Q-wave myocardial infarction; QWMI = Q-wave myocardial infarction; RCA = right coronary artery; ST = stent thrombosis; TLR = target lesion revascularization; TVR = target vessel revascularization; other abbreviations as in Tables 1 and 2.
|